Trends in Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon‑Like Peptide‑1 Receptor Agonist Prescription Rates Among Patients With Type 2 Diabetes: An Epic Cosmos Real-World Data Analysis, 2014-2024
Publication date: July–August 2026 Source: AACE Endocrinology and Diabetes, Volume 13, Issue 4 Author(s): Donglan S. Zhang, Anand Rajan, Shahidul Islam, David M. Charytan, Alan Jacobson, Davene R. Wright, Jordan Weiss, Jasmin Divers
Trends in Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon‑Like Peptide‑1 Receptor Agonist Prescription Rates Among Patients With Type 2 Diabetes: An Epic Cosmos Real-World Data Analysis, 2014-2024. // Academic Pediatrics. – URL: https://www.sciencedirect.com/science/article/pii/S305091572600072X?dgcid=rss_sd_all
Trends in Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon‑Like Peptide‑1 Receptor Agonist Prescription Rates Among Patients With Type 2 Diabetes: An Epic Cosmos Real-World Data Analysis, 2014-2024. Academic Pediatrics. https://www.sciencedirect.com/science/article/pii/S305091572600072X?dgcid=rss_sd_all
“Trends in Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon‑Like Peptide‑1 Receptor Agonist Prescription Rates Among Patients With Type 2 Diabetes: An Epic Cosmos Real-World Data Analysis, 2014-2024.” Academic Pediatrics.
@article{article2425,
title = {Trends in Sodium–Glucose Cotransporter 2 Inhibitor and Glucagon‑Like Peptide‑1 Receptor Agonist Prescription Rates Among Patients With Type 2 Diabetes: An Epic Cosmos Real-World Data Analysis, 2014-2024},
journal = {Academic Pediatrics},
url = {https://www.sciencedirect.com/science/article/pii/S305091572600072X?dgcid=rss_sd_all}
}
Publication date: Available online 14 November 2026 Source: AACE Endocrinology and Diabetes Author(s): Laura Pierotti, Chiara Sardella, Simone Della Valentina, Anna Dal Lago, Giacomo De Leo, Filomena Cetani